The Patent Finder

Zoltan Laboratories LLC

Also on record
Records under this name other than the patents Zoltan Laboratories LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Zoltan Laboratories LLC

PatentTitleStatus Expires Confidence
US 7,781,423Compounds to promote regeneration of bone marrow
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,790,685Combinations of Human Proteins to Enhance Viability of Transplanted Stem Cells and Progenitor Cells
Term ended
Term ended Nov 15, 2026 · High confidence
Term endedTerm ended Nov 15, 2026High confidence
US 8,778,674Combinations of Proteins to Enhance Viability of Stem Cells and Their Progenitors Before Transplantation
Lapsed on the fee record
Ended Jul 15, 2026 · High confidence
Lapsed on the fee recordEnded Jul 15, 2026High confidence
US 8,372,638Combinations of Proteins to Enhance Viability of Stem Cells and Their Progenitors Before Transplantation
Lapsed on the fee record
Ended Feb 12, 2025 · High confidence
Lapsed on the fee recordEnded Feb 12, 2025High confidence
US 7,048,914Placental alkaline phosphatase to control diabetes
Term ended
Term ended Apr 27, 2024 · From the USPTO record
Term endedTerm ended Apr 27, 2024From the USPTO record
US 7,014,852Alkaline phosphatase to induce weight loss or to reduce weight gain
Term ended
Term ended Jan 14, 2024 · From the USPTO record
Term endedTerm ended Jan 14, 2024From the USPTO record
US 7,943,606Compositions and methods to control abnormal cell growth
Formerly held
Lapsed on the fee record
Ended May 17, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 17, 2023From the USPTO record
US 7,858,085Alkaline phosphatase to control diabetes
Term ended
Ended no later than Dec 12, 2022 · From the USPTO record
Term endedEnded no later than Dec 12, 2022From the USPTO record
US 8,603,464Alkaline phosphatase to reduce weight gain or induce weight loss
Lapsed on the fee record
Ended Dec 10, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 10, 2021From the USPTO record
US 7,501,116Placental alkaline phosphatase to control diabetes
Lapsed on the fee record
Ended Mar 10, 2021 · From the USPTO record
Lapsed on the fee recordEnded Mar 10, 2021From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited